The use of recombinant erythropoietin in the reduction of blood transfusion rates in craniosynostosis repair in infants and children

Plastic and Reconstructive Surgery

Volumn 109, Issue 7, 2002, Pages 2190-2196

  Fearon, Jeffrey A ^a   Weinthal, Joel ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRANIOFACIAL SYNOSTOSIS; DRUG EFFICACY; DRUG SAFETY; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

EID: 0036113291     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-200206000-00002     Document Type: Article

References (38)

1. Blood loss and transfusion practice in the perioperative management of craniosynostosis repair
2. Perioperative specific management of blood volume loss in cranio-synostosis surgery
3. Transfusion requirements for craniosynostosis surgery in infants
4. Blood loss during repair of craniosynostosis
5. Factors governing the oxygen affinity of human adult and foetal blood
6. Blood conservation in neonatal and pediatric populations
7. Acquired immunodeficiency in an infant: Possible transmission by means of blood products
8. Tranfusion medicine, first of two parts: Blood transfusions
9. Irradiation in the prevention of transfusion associated graft-versus-host disease
10. Forward: New approaches to surgery blood management
11. No allogenic blood transfusion protocol for the surgical correction of craniosynostoses, I: Rationale
12. Consensus conference: Perioperative red blood cell transfusion
13. Editorial comment
14. Transfusion medicine, second of two parts: Blood conservation
15. Intraoperative autologous blood transfusion in the surgical correction of craniosynostosis
16. Intraoperative autologous blood transfusion in the surgical correction of craniosynostosis
17. Blood loss during repair of craniosynostosis
18. Aprotinin decreases blood loss and homologous transfusions in patients undergoing major orthopedic surgery
19. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization
20. The use of aprotinin reduces blood loss in pediatric craniofacial surgery
21. Avoiding transfusion in head and neck surgery: Feasibility study of erythropoietin
22. An open-label, randomized study to compare the safety and efficacy of perioperative epoetin alfa with periopera-five autologous blood donation in total joint arthroplasty
23. Blood salvage in craniosynostosis surgery
24. Effects of recombinant human erythropoietin on thrombosis and fibrinolysis in autologous transfusion for hip surgery
25. Recombinant human erythropoietin and hemoglobin concentration at operation and during the postoperative period. Reduced need for blood transfusions in patients undergoing colorectal surgery: Prospective double-blinded placebo-controlled study
26. Increased hematocrit and decreased transfusion requirements in children given erythropoietin before undergoing craniofacial surgery
27. The effect of preoperative recombinant human erythropoietin therapy on platelets and hemostasis in patients undergoing cardiac surgery
28. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: Results of randomized clinical trials
29. Purification of human erythropoietin
30. Isolation and characterization of genomic and cDNA clones of human erythropoietin
31. Cloning and expression of the human erythropoietin gene
32. Characterization and biologic effects of recombinant human erythropoietin
33. Enhanced efficacy of autologous blood donation with epoetin alfa
34. Epoetin alfa: A bloodless approach for the treatment of perioperative anemia
35. No allogeneic blood transfusion protocol for the surgical correction of craniosynostoses, II: Clinical application
36. Costs of blood transfusion: A process-flow analysis
37. Cost of outpatient blood transfusion in cancer patients
38. Commentary: Recombinant human erythropoietin and blood management in pediatric spine surgery